A few cell and gene therapy biotechs are doing alright this week. The latest is Neurona Therapeutics, which exclusively told Endpoints News that it collected another $102 million in an upsized, unlabeled round just 14 ...
Neurona is a California-based biotechnology company that researches and develops regenerative cell therapies for the treatment of chronic neurological disorders.